Shares of Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) shot up 1,346.6% during mid-day trading on Friday . The company traded as high as $0.45 and last traded at $0.45. 97 shares traded hands during trading, a decline of 100% from the average session volume of 20,342 shares. The stock had previously closed at $0.03.
Cell MedX Stock Performance
The company has a 50 day moving average price of $0.10 and a two-hundred day moving average price of $0.05.
About Cell MedX
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Read More
- Five stocks we like better than Cell MedX
- Election Stocks: How Elections Affect the Stock Market
- Disney’s Magic Strategy: Reinventing the House of Mouse
- What is Forex and How Does it Work?
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Canadian Penny Stocks: Can They Make You Rich?
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
